PC
| Title | Published in | Access level | OA Policy | Year | Views | Downloads | |
|---|---|---|---|---|---|---|---|
| Risk of first recurrence after treatment in a population-based cohort of young women with breast cancer | Breast cancer research and treatment |  | 2024 | 45 | 22 | ||
| The Communication Chain of Genetic Risk: Analyses of Narrative Data Exploring Proband-Provider and Proband-Family Communication in Hereditary Breast and Ovarian Cancer | Journal of personalized medicine | | 2022 | 54 | 71 | ||
| Swiss cost-effectiveness analysis of universal screening for Lynch syndrome of patients with colorectal cancer followed by cascade genetic testing of relatives | Journal of medical genetics | | 2022 | 53 | 48 | ||
| Intention to Inform Relatives, Rates of Cascade Testing, and Preference for Patient-Mediated Communication in Families Concerned with Hereditary Breast and Ovarian Cancer and Lynch Syndrome: The Swiss CASCADE Cohort | Cancers | | 2022 | 69 | 101 | ||
| Cohort profile: population-based cohorts of patients with colorectal cancer and of their relatives in Geneva, Switzerland | BMJ open | | 2022 | 236 | 58 | ||
| Citizens' views on sharing their health data: the role of competence, reliability and pursuing the common good | BMC Medical Ethics | | 2021 | 220 | 138 | ||
| Ovarian cancer with high-level focal ERBB2 amplification responds to trastuzumab and pertuzumab | Gynecologic Oncology Reports | | 2021 | 218 | 65 | ||
| Genetic Literacy and Communication of Genetic Information in Families Concerned with Hereditary Breast and Ovarian Cancer: A Cross-Study Comparison in Two Countries and within a Timeframe of More Than 10 Years | Cancers | | 2021 | 48 | 52 | ||
| Using a Tailored Digital Health Intervention for Family Communication and Cascade Genetic Testing in Swiss and Korean Families With Hereditary Breast and Ovarian Cancer: Protocol for the DIALOGUE Study | JMIR research protocols | | 2021 | 141 | 65 | ||
| Imaginaires associés aux avancées de la génétique et « médecine du futur » | Áltera | | 2020 | 207 | 52 | ||
| Clinical outcome of breast cancer in carriers of BRCA1 and BRCA2 mutations according to molecular subtypes | Scientific Reports | | 2020 | 289 | 286 | ||
| Concordance of tumour characteristics and survival clustering among pairs of first-degree relatives with breast cancer | Swiss Medical Weekly | | 2020 | 270 | 139 | ||
| Durable response to palbociclib and letrozole in ovarian cancer with CDKN2A loss | Cancer Biology and Therapy | | 2020 | 313 | 119 | ||
| BRCA1/BRCA2 germline mutations and chemotherapy-related hematological toxicity in breast cancer patients | Breast Cancer Research and Treatment |  | 2019 | 392 | 3 | ||
| A new bioinformatics tool to help assess the significance of BRCA1 variants | Human Genomics | | 2018 | 496 | 210 | ||
| Opportunities for improving triple-negative breast cancer outcomes: results of a population-based study | Cancer Medicine | | 2017 | 752 | 312 | ||
| Right colon cancer: Left behind | European journal of surgical oncology | | 2016 | 530 | 414 | ||
| Determinants of genetic counseling uptake and its impact on breast cancer outcome: a population-based study | Breast cancer research and treatment | | 2014 | 604 | 1 | ||
| Impact of family history of breast cancer on tumour characteristics, treatment, risk of second cancer and survival among men with breast cancer | Schweizerische medizinische Wochenschrift | | 2013 | 763 | 425 | ||
| Breast cancer prognosis is inherited independently of patient, tumor and treatment characteristics | International journal of cancer | | 2012 | 553 | 1 | ||
| La communication en oncogénétique : recherche menée aux Hôpitaux Universitaires de Genève | Bulletin de la Société Suisse d'Éthique Biomédicale | | 2010 | 343 | 121 | ||
| Impact of obesity on diagnosis and treatment of breast cancer | Breast cancer research and treatment | | 2010 | 587 | 322 | ||
| Hormonal therapy for oestrogen receptor-negative breast cancer is associated with higher disease-specific mortality | Annals of oncology | | 2009 | 685 | 4 | ||
| Family history of breast or ovarian cancer modifies the risk of secondary leukemia after breast cancer: results from a population-based study | International journal of cancer | | 2008 | 630 | 3 | ||
| Increased risk of second cancer among patients with ovarian borderline tumors | Gynecologic oncology | | 2008 | 567 | 0 | ||
| Epigénétique et cancer | Revue médicale suisse | | 2007 | 540 | 2 | ||
| Complete Excision of Primary Breast Tumor Improves Survival of Patients With Metastatic Breast Cancer at Diagnosis | Journal of Clinical Oncology | | 2006 | 206 | 1 | ||
| Molecular and clinical characteristics in 32 families affected with familial adenomatous polyposis | Human mutation | | 2001 | 704 | 0 | ||
| Introduction | 1989 | 502 | 0 |
